Product
Peginterferon alpha 2a
1 clinical trial
3 indications
Indication
RelapseIndication
Hepatitis CIndication
Genotype 1Clinical trial
Pilot Therapy Using Betaine in Combination With Peginterferon Alpha-2a Plus Ribavirin in Subjects With Genotype 1 Hepatitis C Who Have Not Achieved a Sustained Viral Response With a Prior Course of Pegylated Interferon and RibavirinStatus: Terminated, Estimated PCD: 2011-01-12